As a virologist and a former associate director of the Abramson Cancer Center at the University of Pennsylvania, I observed ...

Gilead Sciences said a combination of its cancer drug Trodelvy and Merck’s Keytruda delayed the growth of tumors in women ...

I share my unique aggressive treatment journey over 11 years, highlighting a common hope for more time and better treatments.

Researchers from Tokyo Metropolitan University have found that the motion of unlabeled cells can be used to tell whether they ...

A new study finds that fragments of tumor DNA in a patient's bloodstream could show that they are at high risk of a melanoma ...

About 40% of women have dense or extremely dense breasts. Online risk assessment tools can help women decide if a breast MRI ...